Clinical Trials Directory

Trials / Completed

CompletedNCT00791960

Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting

Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting: A Randomized, Double Blind, Placebo-Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
149 (actual)
Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study will be to determine whether an intravenous dose of dimenhydrinate (also known as Gravol), given before the induction of spinal anesthesia, will decrease the incidence of intraoperative nausea and vomiting in patients undergoing Cesarean delivery. This medication is commonly given during and after the surgery if required, but it is not known whether a preventative dose will decrease the overall incidence of these side effects.

Detailed description

Nausea and vomiting remain one of the most common complications of Cesarean delivery. The results of this study will show whether or not we can improve our present anesthesia regimen, and improve the satisfaction of patients undergoing Cesarean deliveries, by reducing the incidence of nausea and vomiting. Our current practice is not to use any medication for preventing nausea and vomiting unless required. However, nausea and vomiting come quite fast and unexpectedly during the operation, and most of the time the medication we give does not work fast enough. We are planning to study the anti-nausea medication dimenhydrinate (commonly known as Gravol), which has been safely and widely used during pregnancy, labour and Cesarean deliveries, hoping that its use will decrease the incidence of this unpleasant occurrence.

Conditions

Interventions

TypeNameDescription
DRUGDimenhydrinatesingle dose, 25mg, IV, diluted in 9.5mL normal saline.
OTHERPlacebosingle dose, 10 mL normal saline, IV

Timeline

Start date
2008-11-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2008-11-17
Last updated
2010-03-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00791960. Inclusion in this directory is not an endorsement.